Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Altogen Biosystems公司成立于1978年，是体外诊断工业和全球实验室原材料的主要供应商。我们为我们行业中最大的跨国公司提供广泛的人类纯化蛋白；单克隆和多克隆抗体；真菌、寄生、细菌和病毒抗原；以及用于体外诊断的疾病状态血浆。

Altogen Biosystems is a biotechnology company that develops and manufactures transfection kits for life sciences research, drug discovery and development. Altogen® In Vivo transfection reagents provide effective delivery of biomolecules into target tissues. Cell transfection kits are optimized for specific cancer cell lines and primary cell cultures.  Efficient delivery of cargo molecules (DNA, RNA, proteins) enabled by advanced reagent formulation and optimized transfection protocols. Altogen Biosystems develops new in vitro and in vivo delivery technologies by applying polymer chemistry, molecular and cell biology expertise.

Altogen Biosystems公司的主要产品包括：

Fungal, protozoan, bacterial and viral antigens

Monoclonal antibodies

Polyclonal antibodies

Disease state human plasma

Purified native and recombinant human proteins

GlycoTech公司成立于1991年，是世界上最负盛名的糖生物学公司之一。Glycotech的使命是通过糖基团与它们受体之间的互相作用，发现和筛选出一系列具有药物潜力的化合物。GlycoTech还建立了世界上最大的稀有碳水化合物试剂库之一。

GlycoTech was founded in 1991 and remains today as one of the premier companies focusing on the biological functions and medical applications of glycoconjugates. The company has established its own research programs and has developed a large intellectual property portfolio.  Through its catalog business, GlycoTech has also established one of the largest libraries of rare carbohydrate reagents and technologies worldwide.

GlycoTech的主要产品包括：

Cancer Diagnostics

Human Selectins

Carbohydrate Polymers

Carbohydrate Antibodies

HSA/BSA Conjugates

Cell Adhesion Apparatus

Human Endothelial Cells

Carbohydrates / Reagents

Carbohydrate Adsorbents

Research Protocols

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com